Author(s)

Biya Nkizinkiko Robert¹, Mashako Ruhanga Many^2*

¹Rutshuru Higher Technical Medical Institute and National Tuberculosis and Leprosy Program (NTLP), Goma, Democratic Republic of Congo.
²Health Provincial Ministry of North-Kivu Province and Goma Higher Technical Medical Institute, Goma, Democratic Republic of Congo.

Introduction: The emergency of Mycobacterium tuberculosis resistant to the first line drug reduced access possibility to second line drugs for appropriate treatment and required for urgent action especially in le Democratic Republic of Congo (DRC), which counts among the highest tuberculosis (TB) burden countries in Africa. Objective: To present prevalence and describe multidrug-resistant tuberculosis cases in North-Kivu Province identified by using Genexpert technology. Methods: We conducted an observational prospective study on multidrug-resistant tuberculosis (MDR-TB) cases in North-Kivu Province, DRC from 2017 to 2018. All cases of MDR-TB identified by Genexpert MTB/ RIB were included in this series. Result: Of 15,544 tuberculosis cases registered during the study period, 19 cases of MDR-TB were identified. 57.9% was male, 89.5% was retreatment cases and 5.3% was coinfection HIV/TB cases. Conclusion: This new molecular technology diagnostic facilitates multidrug-resistance tuberculosis detection and improves the reporting of data lack.

Tuberculosis, Drug-Resistance, North-Kivu Province

Robert, B.N. and Many, M.R. (2019) Multidrug-Resistant Tuberculosis Disease in North-Kivu Province, Democratic Republic of Congo. Journal of Tuberculosis Research, 7, 56-64. doi: 10.4236/jtr.2019.72006.